(Reuters) - Pfizer Inc will pay $55 million plus interest to settle charges that Wyeth promoted its acid reflux drug Protonix for unapproved uses and made unproven claims about the medicine, the U.S.
Popular acid reflux drugs such as Prilosec, Nexium, and Protonix may carry hidden risks when taken long term. A new study ...
LOS ANGELES, July 31 (Reuters) - Wyeth and its partner Nycomed said on Tuesday that Teva Pharmaceuticals and Sun Pharmaceuticals have committed to not launching generic versions of heartburn drug ...
Teva has already been awarded a 180-day period of market exclusivity for being the first company to file for a generic version of the drug, which the Food and Drug Administration approved in August.
THE DEAL: Two generic drugmakers will pay $2.15 billion to Pfizer Inc. and Takeda Pharmaceuticals to resolve a lawsuit over the heartburn drug Protonix. THE LAUNCH: Teva Pharmaceutical Industries Ltd.
Pfizer's lawyers at Wilmer Cutler Pickering Hale and Dorr, led by William Lee, had sought a total of $2.5 billion from generic drug makers Teva and Sun at a trial that began last week in Newark. Two ...
NEW YORK (AP) — Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix. Teva Pharmaceutical Industries Ltd., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results